| Pegasys (pegylated interferon α -2a) / Roche |
ChiCTR-TRC-12002116: A multi-center randomized controlled clinical trial on treatment of chronic hepatitis C using Vitamin D combine pegylated interferon + ribavirin |
|
|
| Completed | N/A | 200 | | vitamin D + peg-INF-alpha-2a ;peg-INF-alpha-2a | Department of Infectious Deases of First Teaching Hospital of Xinjiang Medical University; Department of Infectious Deases of First Teaching Hospital of Xinjiang Medical University, Roche China (Shanghai) | Hepatitis C | | | | |
NCT03957629: Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis |
|
|
| Recruiting | N/A | 186 | RoW | Tenofovir Disoproxil Fumarate, Viread, Beixin, PEG-Interferon alfa 2a, Pegasys | Third Affiliated Hospital, Sun Yat-Sen University | Hepatitis B, Liver Fibrosis | 07/21 | 07/23 | | |
| Available | N/A | | Europe, RoW | REP 2139-Mg, Tenofovir Disoproxil Fumarate, Viread, Pegylated interferon alpha2a, Pegasys | Replicor Inc. | Viral Hepatitis B, Viral Hepatitis D, Cirrhosis, Liver, Decompensated Cirrhosis, Ascites Hepatic, Varices, Esophageal, Hepatocellular Carcinoma | | | | |
| Recruiting | N/A | 80 | Europe | Bulevirtide, Entecavir, Tenofovir, Pegasys | University of Athens | Hepatitis D | 11/23 | 12/23 | | |
NCT03771677: To Optimize the Therapeutic Pathway of Peginterferon Treatment in Patients With CHB Based on IFNA2p.Ala120Thr /ISGs. |
|
|
| Recruiting | N/A | 400 | RoW | Nucleotide Analog, Nucleotide Analogs, Interferon Alfa-2A, Pegasys | Sun Yat-sen University, First People's Hospital of Foshan, Eighth Affiliated Hospital, Sun Yat-sen University | Hepatitis B | 12/23 | 12/24 | | |
